Robotic Endoscopy Devices Market

The market for Robotic Endoscopy Devices was estimated at $2.8 billion in 2025; it is anticipated to increase to $5.0 billion by 2030, with projections indicating growth to around $9.0 billion by 2035.

Report ID:DS1801088

Author:Debadatta Patel - Senior Consultant

Published Date:January 2025

Datatree

Life Science

Medical Device

Robotic Endoscopy Devices

Customization Available

Robotic Endoscopy Devices - 2025-2035

Market Outlook
Market Key Insights
Growth Opportunity
Market Dynamics
Application
Recent Development
Impact Analysis

Report Summary

Market Data

Methodology

Table of Contents

Report Summary

Market Data

Methodology

Table of Contents

Global Robotic Endoscopy Devices Market Outlook

Revenue, 2025

$2.8B

Forecast, 2035

$9.0B

CAGR, 2026 - 2035

12.3%

The Robotic Endoscopy Devices industry revenue is expected to be around $2.8 billion in 2026 and expected to showcase growth with 12.3% CAGR between 2026 and 2035. Currently, robotic endoscopy technology has become a critical component of the strategies employed by both hospital and ambulatory care settings. This comes from the fact that medical staff are striving to achieve more positive clinical results by reducing the rate of associated problems and standardising complex endoscopic procedures through greater precision and automation. Therapeutic endoscopes are predicted to be the leading product, generating $1.56 billion in revenue by the year 2025. Laparoscopy and colonoscopy applications together account for 71.0% of the total demand. As a result, much investment is going into robotic endoscopy systems capable of safely and efficiently addressing high volume gastrointestinal procedures. Demand for endoscopic robotics is also being driven by the preference for robot assisted endoscopy as a solution to staff shortages, providing the benefit of 3D vision, assisted navigation, integration with the operating theatre and new possibilities in both remote and disposable endoscopes.

Endoscopic robotic systems bring together surgical equipment with either flexible or stiff endoscopes to provide internal access through precise, stable and dexterous movement. This is done by combining high definition imaging and multi degree of freedom control over instruments with elimination of unwanted movement and ergonomically designed consoles for the surgeon. Applications for robotic endoscopy technology include complex urological and bronchoscopic procedures as well as robotic colonoscopy and robotic laparoscopy. Such robotic systems are also used for endoscopic submucosal dissection, precise lesion resection, diagnostic visualisation and targeted biopsy procedures. Growing demand for endoscopic robots can be attributed to a number of factors including the wider use of the technology for endoscopy, technical advancements which have led to smaller and more versatile equipment, the integration of data and imaging systems, and the fact that the treatment can now be performed outside of hospital environments. The endoscopic robotic market thus stands at the forefront of the next wave of minimal surgical intervention.

Robotic Endoscopy Devices market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035 — Robotic Endoscopy Devices Market Outlook

Market Key Insights

The Robotic Endoscopy Devices market is projected to grow from $2.8 billion in 2025 to $9.0 billion in 2035. This represents a CAGR of 12.3%, reflecting rising demand across Bronchoscopy, Laparoscopy, and Colonoscopy.
This market is dominated by a number of major corporations including Olympus Corporation, Medtronic PLC and Johnson & Johnson.
The United States and China will be the leading countries in the field of robotic endoscopy equipment by 2025. The annual growth rate for these countries between 2025 and 2030 is expected to range from 11.1% to 14.8% .
The countries with the highest growth rates, with a compound annual growth rate ranging from 8.6% to 12.9%, are likely to be found among the emerging markets of India, South Korea and Brazil.
Advances in technology associated with robotic endoscopy is likely to augment the robotic endoscopy devices market significantly by 2030 with an increase of $331 million.
Over the forthcoming years, robotic endoscopy devices are predicted to increase their revenue by $6.2 billion by 2035. They will achieve this with their focus on the bronchoscopy and colonoscopy applications.
The growing use of minimally invasive surgery coupled with the increasing healthcare expenditure and infrastructure development is seen to stimulate the demand for robotic endoscopy devices. This is expected to increase the market for such devices by 219% by 2035.

Robotic Endoscopy Devices - Country Share Analysis

Opportunities in the Robotic Endoscopy Devices

The use of tele operated robotic endoscopy technology allows for rural region's in both China and India where there is also a shortage of medical specialists to carry out diagnostic procedures remotely. Using AI assisted lesion detection, 5G connectivity and augmented reality these procedures and surgeries are performed remotely at clinics, hospitals and in endoscopy centers. Diagnostic endoscopes will command the largest market size growing from $1.26 billion in 2025 to $2.05 billion in 2030, this will occur due to governments placing greater emphasis on the early detection of cancer and the access to gastrointestinal care for everyone.

Growth Opportunities in North America and Asia-Pacific

North America's robotic endoscopy device market is being driven by the strong adoption of minimally invasive surgery coupled with robust reimbursement policies for complex endoscopic procedures. Key applications are seen in the region's of robotic colonoscopy and robotic laparoscopy, partly due to well established screening and testing protocols and an increasing need for precise oncology. Key region's for investment include transforming traditional endoscopy facilities into integrated operating theatres which combine robotic endoscopic procedures with digital imaging technologies, particularly in large teaching hospitals and other major medical research institutions. Rising are pressures on established robotic systems for surgery that use cameras because these are being challenged by smaller innovative manufacturers of endoscopic robots and firms that make single use endoscopes. Regional drivers include a growing older population, stringent quality and safety norms and the desire to reduce complication rates and the time taken for surgical procedures through the automation of the health service, tending to create a niche for robotic endoscopic surgery equipment.

Asia Pacific robotic endoscopy devices have their strongest applications in bronchoscopy and in gastrointestinal endoscopy. There is considerable growth potential for such devices in the regions tertiary hospitals and in high volume cancer centres. This is on account of rising incidence rates of respiratory and digestive diseases, combined with the fact that robotic endoscopy infrastructure in the region is underdeveloped. The possibilities lie in the use of robot assisted endoscopic equipment which is cost effective. It is to be used in various different countries where there are different budget levels for healthcare. Furthermore there could be programmes to teach people how to do operations using keyhole surgery. The market is marked by both established global producers of medical equipment and rapidly growing regional companies producing flexible and rigid endoscopic robotic systems. They often compete with other companies on price and the extent of the services offered rather than the companys brand. The main growth drivers for this sector are investment in government backed robotic surgical technologies, the development of private hospital chains and the shift to early diagnosis and treatment. This allows for the integration of robotic endoscopy devices that utilise AI, along with digital surgery platforms that can be scaled up.

Market Dynamics and Supply Chain

Driver: Rising Demand for Minimally Invasive Procedures and Integration of Advanced Imaging Technologies

The robotic endoscopy devices market is also driven by the increasing preference for minimally invasive procedures and the rapid adoption of advanced imaging technologies. Minimally invasive endoscopic surgeries reduce patient trauma, shorten hospital stays, and lower complication rates, prompting hospitals and surgical centers to invest in robotic platforms that offer precision beyond traditional endoscopy. At the same time, integration of high‑definition visualization, real‑time 3D imaging, and fluorescence guidance enhances lesion detection, navigation, and surgical accuracy. These imaging improvements reduce diagnostic errors and expand surgical applications across gastrointestinal, pulmonary, and urological fields. For example, combination of optical coherence tomography and AI‑enhanced endoscopic imaging enables clinicians to visualize subtle mucosal changes, supporting early cancer detection. Together, these trends broaden clinical utility, drive procedure volumes, and strengthen adoption of robotic endoscopic systems in both urban and remote care settings, especially among advanced health systems prioritizing quality outcomes and efficiency.

A key driver for robotic endoscopy devices is also the integration of AI‑powered navigation and remote procedural support. AI algorithms improve anatomical mapping, automate instrument guidance, and reduce dependency on surgeon experience, making complex endoscopic interventions more consistent and accessible. Remote support capabilities enable expert clinicians to assist or perform procedures across geographical barriers, expanding access in underserved regions. These advancements enhance workflow efficiency, reduce learning curves, and position robotic endoscopy as a future‑oriented solution in digital surgery and precision medicine.

Restraint: High Capital Outlay and Operational Costs Limit Adoption in Smaller Facilities

A critical restraint for robotic endoscopy devices is the high upfront investment and ongoing operating expenses required to acquire and maintain these systems. Many robotic platforms cost several hundreds of thousands to over a million dollars, including consumables and periodic servicing, which smaller hospitals and clinics often cannot justify against budget constraints. This restricts accessibility, particularly in emerging markets and rural regions, limiting procedure volumes, compressing revenue growth for vendors, and slowing broader clinical uptake despite clinical advantages.

Opportunity: Accelerating adoption of robotic diagnostic endoscopy in gastrointestinal screening programs across US and European hospitals. and Underpenetrated ambulatory surgery centers across Asia-Pacific adopting robotic therapeutic endoscopy for complex interventions.

The market for robotic endoscopes used in the diagnosis of gastrointestinal disorders is expected to grow rapidly as more US and European hospitals put into place screening programmes for cancer. This upturn will also be due to a heightened demand for minimal invasiveness in medical treatments. Diagnostic endoscopes will generate $1.26 billion by 2025 and are predicted to reach $2.05 billion by the year 2030 with a compound annual growth rate of 10.2%. This growth rate is greater than that of therapeutic endoscopes. The integration of AI technology in endoscopy and automation systems used in hospitals will probably prompt a move away from the older flexible endoscopes in the investigation and treatment of cancers of the colon and the upper digestive system.

The Asia Pacific region is home to a significant number of underdeveloped ambulatory surgery clinics, which provide considerable growth opportunities for robotic endoscopy products, especially those with therapeutic capabilities. By 2025, endoscopic therapy equipment will be worth 1.56 billion dollars. This market is expected to grow at a rate of 6.66% per annum from 2030, when it will be worth 2.15 billion dollars, due to a rise in the number of people who have access to healthcare. Technological advancements will mean that more patients undergo procedures like endoscopic sub mucosal dissection, polypectomy or gastric banding revision in outpatient facilities. Those procedures where a therapeutic endoscope is used will grow quickest in this setting.

Challenge: Steep Learning Curve, Skilled Workforce Shortages, and Integration Challenges Hinder Clinical Adoption

Another major restraint is the complex training requirements and shortage of skilled professionals capable of operating sophisticated robotic endoscopy systems. Effective use demands extensive training and familiarity with advanced robotic controls, which many healthcare facilities, especially in developing regions, lack. The technical and workflow integration challenges further slow adoption, as clinicians may resist transitioning from conventional endoscopy, ultimately affecting demand behavior and market expansion despite clear clinical benefits.

Supply Chain Landscape

Endoscopic Imaging Manufacturing

Olympus CorporationMedtronic PLCJohnson & Johnson

Robotic Endoscopy Devices

Intuitive Surgical Inc.Asensus Surgical Inc.Johnson & Johnson

Surgical Navigation Services

Medtronic PLCOlympus CorporationIntuitive Surgical Inc

Clinical End-Users

Tertiary Care HospitalsAmbulatory Surgical CentersMinimally Invasive Surgery Centers

Endoscopic Imaging Manufacturing

Olympus CorporationMedtronic PLCJohnson & Johnson

Robotic Endoscopy Devices

Intuitive Surgical Inc.Asensus Surgical Inc.Johnson & Johnson

Surgical Navigation Services

Medtronic PLCOlympus CorporationIntuitive Surgical Inc

Clinical End-Users

Tertiary Care HospitalsAmbulatory Surgical CentersMinimally Invasive Surgery Centers

Robotic Endoscopy Devices - Supply Chain

Use Cases of Robotic Endoscopy Devices in Bronchoscopy & Laparoscopy

Bronchoscopy : Robotic endoscopy devices for bronchoscopy primarily include advanced robotic bronchoscopic systems that combine robotic arms, high‑definition imaging, and navigation software to access deep lung regions for biopsy and diagnosis of pulmonary conditions. These robotic solutions enhance precision, improve lesion targeting, and reduce procedure times compared with conventional bronchoscopes, benefiting hospitals and specialty respiratory centers. Key providers such as Intuitive Surgical, Johnson & Johnson’s Auris Health, Medtronic’s robotic bronchoscopy systems, and Olympus lead this segment with strong product portfolios, clinical support, and global distribution, driving adoption in minimally invasive pulmonary care.

Laparoscopy : Robotic endoscopy devices for laparoscopy are increasingly adopted in minimally invasive surgery to enhance precision and control in abdominal and pelvic procedures. Advanced robotic platforms such as Intuitive Surgical’s da Vinci systems, Medrobotics’ flexible robotics, and AI‑integrated visualization tools are commonly used by surgeons to improve dexterity, 3D imaging, and ergonomic performance during laparoscopic operations. These technologies help reduce tissue trauma, shorten recovery times, and expand surgical capabilities in hospitals and specialty surgical centers. Leading market players like Intuitive Surgical, Medtronic, Olympus, Johnson & Johnson (Auris Health), and Asensus Surgical invest in product innovation and clinical support to strengthen their positions in the growing robotic laparoscopy segment.

Colonoscopy : Robotic endoscopy devices play a growing role in colonoscopy by providing advanced robotic‑assisted colonoscopy systems that enhance maneuverability, real‑time visualization, and diagnostic precision for colorectal cancer screening and polyp detection. These robotic platforms-often flexible, self‑propelling, or AI‑assisted-improve patient comfort, reduce discomfort, and support both diagnostic and therapeutic gastrointestinal procedures in hospitals and outpatient clinics. Leading providers such as Medtronic plc with AI‑enabled systems, Intuitive Surgical with robotic navigation technologies, and Olympus Corporation with enhanced robotic endoscopy solutions are strengthening their competitive positions through innovation, expanded capabilities, and broader clinical adoption. Robotic colonoscopy adoption is rising due to increasing colorectal disease prevalence and demand for minimally invasive procedures with superior control and outcomes.

Recent Developments

Recent developments in robotic endoscopy devices reflect strong momentum in minimally invasive surgery, tele-guided procedures, and advanced imaging integration. Leading firms are enhancing robotic platforms with improved articulation, real‑time visualization, and AI‑assisted navigation, expanding applications in bronchoscopy, gastrointestinal, and remote surgical workflows. A key market trend is the convergence of telehealth and robotic systems, enabling specialists to support endoscopic procedures from afar, boosting access in underserved regions and strengthening hospital investment in digital surgery and precision intervention technologies.

January 2025 : Intuitive Surgical Inc. announced plans to establish a direct presence in Italy, Spain, Portugal, Malta, and San Marino by acquiring their regional distribution channels for da Vinci and Ion robotic platforms. This strategic expansion enhances market access for its robotic endoscopy and minimally invasive systems across Southern Europe, strengthening clinical adoption and brand reach.

August 2024 : Asensus Surgical Inc. was acquired by KARL STORZ Group, augmenting the latter’s capabilities in robotic‑assisted surgery, including future robotic endoscopy integration. This corporate move enhances global distribution and technology synergies.

April 2024 : Medtronic plc expanded its AI‑powered GI Genius endoscopy platform across Europe and Asia‑Pacific, combining artificial intelligence with robotic endoscopic workflows to improve procedure accuracy and diagnostics in colorectal cancer screening.

Impact of Industry Transitions on the Robotic Endoscopy Devices Market

As a core segment of the Medical Device industry, the Robotic Endoscopy Devices market develops in line with broader industry shifts. Over recent years, transitions such as Technological Advancements in Robotic Endoscopy and Expansion of Telehealth have redefined priorities across the Medical Device sector, influencing how the Robotic Endoscopy Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

Technological Advancements in Robotic Endoscopy

Robotic endoscopy equipment is undergoing advancements in technology, with the consequence that by 2030 endoscopy is likely to be carried out by AI controlled robotic systems instead of the traditional endoscopy. This could add $331 million in additional sales by 2030. The benefits of enhanced precision, real time endoscope navigation and safer procedures, are helping to bring about an increase in the use of minimally invasive surgery and in gastrointestinal tests, making robotic endoscopy a worthwhile investment for surgical centres and hospitals. Clinical applications are being widened by capsule endoscopy and miniaturized surgical robots to region's of the body that previously were unreachable, plus remote control endoscopes reduce risks and enhance efficiency. Not only are these advances in technology increasing the quality of treatment, they are also enlarging the market for robotic endoscopy systems by means of increased numbers of procedures, higher prices, and more frequent replacement of equipment.

Expansion of Telehealth

The rapid expansion of telehealth and remote care has significantly influenced the robotic endoscopy devices market. Robotic systems now allow clinicians to perform minimally invasive procedures remotely or guide local teams during complex endoscopic interventions, improving access for patients in rural or underserved areas. For example, hospitals using Intuitive Surgical’s da Vinci or Johnson & Johnson’s Monarch platforms can integrate remote monitoring and teleconsultation, reducing patient travel and infection risk. This transition also impacts digital health, medical IT, and telemedicine industries, driving demand for secure data transmission, real‑time imaging, and cloud-based surgical platforms. Consequently, robotic endoscopy devices are increasingly positioned as critical tools for expanding virtual care models, enhancing procedural efficiency, and integrating advanced healthcare technologies across connected clinical ecosystems.